Skip to main content
Year archive

AstraZeneca Pharma India Ltd. — 2021 filings

All 121 regulatory filings released by AstraZeneca Pharma India Ltd. (ASTRAZEN) in 2021, sourced directly from the official regulator.

121 Filings
2021 Period
2021 filings (121)
Filing Released Lang
In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015), we wish to inform you that the Board of Directors of the Company based on the recommendations ..
Regulatory Filings
2021-12-30 English
Appointment
Regulatory Filings
2021-12-30 English
Loss of Share Certificates
Regulatory Filings
2021-12-23 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings
2021-12-23 English
Trading Window
Regulatory Filings
2021-12-17 English
This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing ....
Regulatory Filings
2021-12-17 English
We hereby inform that an interaction with individual shareholder/investor is scheduled to be held as per the details attached
Regulatory Filings
2021-12-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-12-10 English
We are enclosing herewith Certificate dated December 2, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings
2021-12-08 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings
2021-12-08 English
Updates
Regulatory Filings
2021-12-08 English
Loss of Share Certificates
Regulatory Filings
2021-12-08 English
Updates
Regulatory Filings
2021-11-29 English
Related Party Transactions
Regulatory Filings
2021-11-29 English
We are enclosing herewith Certificate dated November 3, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings
2021-11-29 English
Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party ....
Regulatory Filings
2021-11-29 English
Loss of Share Certificates
Regulatory Filings
2021-11-17 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings
2021-11-17 English
Financial Result Updates
Regulatory Filings
2021-11-09 English
At the Board meeting of the Company held on Tuesday, November 9, 2021 the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended ....
Regulatory Filings
2021-11-09 English
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2021 ,inter alia, to consider and approve This is to inform ....
Regulatory Filings
2021-11-02 English
Board Meeting — Financial Results
Regulatory Filings
2021-11-02 English
Updates
Regulatory Filings
2021-10-13 English
Loss of Share Certificates
Regulatory Filings
2021-10-13 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings
2021-10-13 English
We are enclosing herewith Certificate dated October 6, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings
2021-10-13 English
Loss of Share Certificates
Regulatory Filings
2021-09-29 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings
2021-09-29 English
Updates
Regulatory Filings
2021-09-26 English
This is to inform that AstraZeneca Pharma India Limited has received Import and Market Permission in Form CT-20 from the Drugs Controller General of India for Selumetinib 10 mg & 25 mg capsule. ....
Regulatory Filings
2021-09-26 English
Trading Window
Regulatory Filings
2021-09-16 English
This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing ....
Regulatory Filings
2021-09-16 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform that at the Company's 42nd Annual General Meeting held on August ....
Regulatory Filings
2021-08-10 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform that at the Company's 42nd Annual General Meeting held on August ....
Regulatory Filings
2021-08-10 English
Updates
Regulatory Filings
2021-08-10 English
Appointment
Regulatory Filings
2021-08-10 English
Pursuant to Clause 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the details regarding voting results of 42nd Annual General ....
Regulatory Filings
2021-08-10 English
Shareholders meeting
Regulatory Filings
2021-08-10 English
AstraZeneca Pharma India Ltd has informed BSE that the Company has fixed August 20, 2021 as the Record Date for the purpose of Payment of Interim Dividend.
Regulatory Filings
2021-08-10 English
Pursuant to the provisions of Regulation 30 read with Part A of Schedule III to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that ....
Regulatory Filings
2021-08-09 English
Shareholders meeting
Regulatory Filings
2021-08-09 English
We would wish to inform that at the Meeting of the Board of Directors of the Company held today i.e., on August 9, 2021, the Board have inter-alia declared an Interim Dividend of Rs. 2 ....
Regulatory Filings
2021-08-09 English
Dividend
Regulatory Filings
2021-08-09 English
Record Date
Regulatory Filings
2021-08-09 English
AstraZeneca Pharma India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2021, inter alia, has declared Interim Dividend of Rs. 2 per equity ....
Regulatory Filings
2021-08-09 English
The Board of Directors of the Company at their meeting held today i.e, August 9, 2021, has inter-alia: 1. Approved the Unaudited Financial Results of the Company for the quarter ....
Regulatory Filings
2021-08-09 English
Financial Result Updates
Regulatory Filings
2021-08-09 English
AstraZeneca Pharma India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 09, 2021, inter alia, to:1. consider and approve the ....
Regulatory Filings
2021-08-02 English
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2021 ,inter alia, to consider and approve i. the Unaudited ....
Regulatory Filings
2021-08-02 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2021-08-02 English
Updates
Regulatory Filings
2021-07-27 English
We are enclosing herewith Certificate dated July 12, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings
2021-07-27 English
Copy of Newspaper Publication
Regulatory Filings
2021-07-20 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing a copy of newspaper advertisement published in Business Standard ....
Regulatory Filings
2021-07-20 English
Shareholders meeting
Regulatory Filings
2021-07-16 English
Pursuant to Regulation 34(1) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed the Annual Report of the Company for the financial year ....
Regulatory Filings
2021-07-16 English
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the Notice of the 42nd Annual General ....
Regulatory Filings
2021-07-16 English
Loss of Share Certificates
Regulatory Filings
2021-07-09 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2021-07-09 English
In terms of SEBI's Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, we furnish herewith the Secretarial Compliance Report, for the year ended March 31, 2021.
Regulatory Filings
2021-06-29 English
Copy of the intimation pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, pertaining to notice of demand from National Pharmaceutical ....
Regulatory Filings
2021-06-29 English
Updates
Regulatory Filings
2021-06-29 English
Updates
Regulatory Filings
2021-06-11 English
We are enclosing herewith Certificate dated June 4, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings
2021-06-11 English
Related Party Transactions
Regulatory Filings
2021-06-02 English
Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party ....
Regulatory Filings
2021-06-02 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing a copy of newspaper advertisement published in Business Standard ....
Regulatory Filings
2021-05-28 English
Copy of Newspaper Publication
Regulatory Filings
2021-05-28 English
Updates
Regulatory Filings
2021-05-28 English
We refer to our announcement of December 7, 2018, wherein we had informed about the Distribution Agreement entered into between AstraZeneca Pharma India Limited (AstraZeneca India) and ....
Regulatory Filings
2021-05-28 English
We refer to our announcement of March 23, 2016, wherein we had informed about the Distribution Services Agreement entered into between AstraZeneca Pharma India Limited (AstraZeneca India) ....
Regulatory Filings
2021-05-28 English
Updates
Regulatory Filings
2021-05-28 English
We are enclosing herewith Certificate dated May 4, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings
2021-05-26 English
Updates
Regulatory Filings
2021-05-26 English
Updates
Regulatory Filings
2021-05-26 English
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at their meeting held on May ....
Regulatory Filings
2021-05-26 English
The Board of Directors of the Company at their meeting held on May 25, 2021, have, inter alia, approved the Re-appointment of M/s. Price Waterhouse & Co. Chartered Accountants LLP (ICAI ....
Regulatory Filings
2021-05-26 English
The Board of Directors of the Company at their meeting held on May 25, 2021, have, inter alia, approved the re-appointment of Ms. Revathy Ashok (DIN 00057539) as an Independent Director ....
Regulatory Filings
2021-05-26 English
Outcome of Board Meeting
Regulatory Filings
2021-05-26 English
Outcome of Board Meeting
Regulatory Filings
2021-05-26 English
At the Board meeting of the Company held on Tuesday, May 25, 2021 the Board of Directors considered and approved the Audited Financial Results of the Company for the quarter and year ended ....
Regulatory Filings
2021-05-25 English
At the Board meeting of the Company held on Tuesday, May 25, 2021 the Board of Directors considered and approved the Audited Financial Results of the Company for the quarter and year ended ....
Regulatory Filings
2021-05-25 English
Financial Result Updates
Regulatory Filings
2021-05-25 English
Board Meeting — Financial Results
Regulatory Filings
2021-05-18 English
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2021 ,inter alia, to consider and approve This is to inform ....
Regulatory Filings
2021-05-18 English
Price movement
Regulatory Filings
2021-04-28 English
We refer to our earlier communication dated December 20, 2020 intimating the receipt of Import and Market Permission in Form CT-20 (Marketing Authorization- Additional Indication) from ....
Regulatory Filings
2021-04-20 English
Updates
Regulatory Filings
2021-04-20 English
As required under Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we furnish herewith a Certificate issued by the Practicing Company Secretary ....
Regulatory Filings
2021-04-16 English
As required under Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we furnish herewith a Certificate issued by the Practicing Company Secretary ....
Regulatory Filings
2021-04-16 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2021-04-15 English
This is to certify that, Integrated Registry Management Services Private Limited are the Company's Registrar and Transfer Agents and that all activities in relation to the share transfer ....
Regulatory Filings
2021-04-09 English
We are enclosing herewith Certificate dated April 5, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings
2021-04-09 English
Updates
Regulatory Filings
2021-04-09 English
Annual Disclosure
Regulatory Filings
2021-04-09 English
We are enclosing herewith Certificate dated March 2, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings
2021-03-26 English
Updates
Regulatory Filings
2021-03-26 English
Loss of Share Certificates
Regulatory Filings
2021-03-17 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2021-03-17 English
Updates
Regulatory Filings
2021-03-10 English
This is to inform that AstraZeneca Pharma India Limited has received Import and Market Permission in Form CT-20 (Subsequent New Drug Approval) from the Drugs Controller General of India ....
Regulatory Filings
2021-03-10 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2021-03-06 English
Loss of Share Certificates
Regulatory Filings
2021-03-06 English
Loss of Share Certificates
Regulatory Filings
2021-02-14 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2021-02-14 English
Updates
Regulatory Filings
2021-02-12 English
Copy of Newspaper Publication
Regulatory Filings
2021-02-12 English
We are enclosing herewith Certificate dated February 5, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings
2021-02-12 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing a copy of newspaper advertisement published in Business Standard ....
Regulatory Filings
2021-02-12 English
At the Board meeting of the Company held on Monday, February 8, 2021 the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended ....
Regulatory Filings
2021-02-08 English
Financial Result Updates
Regulatory Filings
2021-02-08 English
This is to inform that AstraZeneca Pharma India Limited has received Import and Market Permission in Form CT-20 (Subsequent New Drug Approval) from the Drugs Controller General of India ....
Regulatory Filings
2021-02-06 English
Updates
Regulatory Filings
2021-02-06 English
Copy of Newspaper Publication
Regulatory Filings
2021-02-05 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing a copy of newspaper advertisement published in Business Standard ....
Regulatory Filings
2021-02-05 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2021-02-03 English
Loss of Share Certificates
Regulatory Filings
2021-02-03 English
Board Meeting — Financial Results
Regulatory Filings
2021-01-29 English
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2021 ,inter alia, to consider and approve the Unaudited Financial ....
Regulatory Filings
2021-01-29 English
Updates
Regulatory Filings
2021-01-27 English
We are enclosing herewith Certificate dated January 1, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings
2021-01-27 English